주입 펌프 시장 : 용도별, 최종 사용자별, 지역별, 범위 및 예측(2024-2031년)

Infusion Pump Market Valuation - 2024-2031

The infusion pump market is expanding rapidly due to increased demand for innovative medical equipment that enables precise and controlled delivery of fluids, drugs, and nutrition to patients. These pumps are vital in hospitals and home care settings, particularly for patients who need continuous infusion treatments such as pain management, chemotherapy, and insulin therapy. Thus, the growing demand for infusion pumps surged the growth of market size surpassing USD 15.12 Billion in 2024 to reach a valuation of USD 24.09 Billion by 2031.

Technological improvements, such as smart pumps with improved safety and connection, are boosting their acceptance. The increasing prevalence of chronic diseases, combined with the growing older population, is further fueling the demand for infusion pumps, positioning the market for continued growth. Thus, the growing popularity of remote connectivity enables the market to grow at a CAGR of 6.00% from 2024 to 2031.

Infusion Pump Market: Definition/ Overview

An infusion pump is a medical device that supplies fluids, such as drugs, nutrients, or blood, to a patient's body in a controlled manner. These pumps are widely utilized in hospitals, clinics, and home care settings, where they ensure accurate delivery rates over a predetermined period, making them critical for treatments such as chemotherapy, pain management, and intravenous feeding.

Infusion pumps are widely used to administer supplements or medications to patients, such as insulin, hormones, antibiotics, chemotherapy drugs, and pain relievers. These devices offer several advantages over manual fluid administration, including the ability to deliver fluids in very small volumes at precisely programmed rates or at automated intervals. Emerging markets, such as India and China, present significant growth opportunities for players in the infusion pump market, alongside the increasing adoption of specialty pumps.

How Does the Increasing Prevalence of Chronic Diseases Surge the Growth of Infusion Pump Market?

The increased prevalence of chronic diseases among the elderly drives the need for infusion pumps. As people age, they become more susceptible to conditions such as diabetes, cardiovascular diseases, and cancer, which often require long-term medication administration. Infusion pumps provide an efficient and accurate method for delivering these medications, allowing for better management of chronic conditions. This is particularly crucial for elderly patients who may have complex treatment regimens or require multiple medications, as infusion pumps can be programmed to deliver precise dosages at specific intervals.

Furthermore, the shift towards home healthcare and the desire for improved quality of life among the elderly population boosts the demand for portable and user-friendly infusion pumps. Many older adults prefer to receive treatment in the comfort of their homes rather than in hospital settings. Advances in infusion pump technology have made these devices more compact, easier to use, and suitable for home care. This trend not only improves patient comfort and independence but also helps reduce healthcare costs associated with prolonged hospital stays, making infusion pumps an increasingly essential component of elderly care.

What Role Does Competitive Pricing Play in Influencing the Adoption of Infusion Pumps Among Healthcare Facilities?

Budget constraints and cost-effectiveness considerations significantly impact healthcare facilities' purchasing decisions for medical equipment, including infusion pumps. As healthcare providers face increasing pressure to manage costs while maintaining high-quality care, the price point of infusion pumps becomes a critical factor. Competitively priced pumps that offer reliable performance and essential features are more likely to be adopted, especially by smaller healthcare facilities or those in resource-constrained settings. This pricing strategy allows facilities to acquire necessary equipment without overstretching their budgets, enabling them to allocate resources to other critical areas of patient care.

Furthermore, the long-term cost implications associated with infusion pump ownership and maintenance also influence adoption rates. Healthcare facilities consider not only the initial purchase price but also ongoing expenses such as maintenance, repairs, and consumables. Manufacturers offering competitively priced pumps often provide cost-effective service plans, replacement parts, and compatible disposables. This comprehensive approach to pricing can make certain infusion pump models more attractive to healthcare facilities, as it allows for better long-term budget planning and potentially lower total cost of ownership. Consequently, competitive pricing strategies that address both upfront and long-term costs can significantly drive the adoption of infusion pumps across various healthcare settings.

Category-Wise Acumens

How does the Increasing Demand for Chemotherapy/Oncology Treatments Influence the Adoption of Infusion Pumps in Hospitals?

The chemotherapy/oncology segment dominates in the infusion pump market owing to the precision and safety requirements in chemotherapy administration drive the need for advanced infusion pumps. Chemotherapy drugs often require exact dosing and controlled delivery rates to maximize effectiveness while minimizing side effects. Modern infusion pumps offer programmable features that allow for precise control over drug delivery, including multi-step infusions and time-specific dosing schedules. This level of accuracy is crucial in oncology treatments, where even small variations in drug administration can impact treatment efficacy and patient safety. Consequently, hospitals are increasingly adopting smart infusion pumps with built-in safety features and drug libraries specific to oncology protocols.

The rise in outpatient and ambulatory cancer care services fuels the demand for portable and versatile infusion pumps. As more cancer treatments shift from inpatient to outpatient settings, hospitals require infusion pumps that can seamlessly transition between different care environments. Portable pumps allow patients to receive continuous treatment while maintaining mobility, improving their quality of life during lengthy chemotherapy regimens. This trend has led to increased adoption of lightweight, battery-operated infusion pumps that can be easily programmed for home use or monitored remotely by healthcare providers, enhancing the flexibility of cancer care delivery in hospital-affiliated outpatient clinics and home settings.

How does the Complex Drug Protocol and Need for Intricate Treatment Foster the Growth of Hospital Segment?

The hospital segment dominates the infusion pump market driven by the complexity of drug protocols and dosing regimens in hematology poses a major challenge. Hematological conditions often require intricate treatment plans involving multiple medications, precise dosing schedules, and frequent adjustments based on patient response. Integrating infusion pumps to accurately deliver these complex regimens demands sophisticated programming capabilities and seamless integration with electronic health records (EHR) systems. Hospitals must ensure that their infusion pumps can handle multi-step infusions, drug sequencing, and rapid protocol changes, which often necessitates investment in advanced smart pumps and extensive staff training to minimize errors and optimize treatment efficacy.

Furthermore, Compatibility issues with blood products and specialized hematology medications create another significant hurdle. Many hematology treatments involve the infusion of blood products, clotting factors, or highly viscous medications that may not be compatible with standard infusion pump settings. Hospitals must carefully select pumps that can handle these specialized products without compromising their integrity or causing equipment malfunction. Additionally, the risk of medication errors is heightened due to the critical nature of many hematology treatments. This requires hospitals to implement robust safety features, including barcode scanning, drug libraries specific to hematology, and alert systems to prevent potentially life-threatening mistakes during infusion therapy.

Country/Region-wise Acumens

What Impact do Regulatory Standards in North America have on the Development and Adoption of Infusion Pump Technologies?

North America substantially dominates the infusion pump market owing to the stringent safety and performance requirements set by regulatory bodies like the U.S. Food and Drug Administration (FDA) drive innovation in infusion pump design. These regulations mandate rigorous testing and validation processes to ensure pump reliability, accuracy, and safety. Manufacturers must demonstrate compliance with standards such as IEC 60601-1 for electrical safety and IEC 60601-2-24 for infusion pump performance. This regulatory environment pushes companies to invest heavily in research and development, resulting in advanced features like integrated drug libraries, dose error reduction systems, and interoperability capabilities. While these requirements can extend development timelines and increase costs, they ultimately lead to safer, more effective infusion pump technologies that healthcare providers can trust.

Furthermore, Regulatory oversight also influences the adoption rate of new infusion pump technologies in healthcare settings. The FDA's premarket approval (PMA) process for Class III medical devices, which includes many advanced infusion pumps, involves extensive clinical trials and data submission. This rigorous approval pathway can slow the introduction of novel technologies to the market. However, it also instills confidence among healthcare providers and patients, facilitating faster adoption once approval is granted. Additionally, regulatory bodies' post-market surveillance requirements, such as the FDA's adverse event reporting system, encourage ongoing improvements and updates to existing pump technologies. This continuous feedback loop between regulators, manufacturers, and end-users fosters a culture of constant innovation and refinement in the infusion pump industry.

How does the Healthcare Infrastructure in the Middle East & Africa Affect the Availability and Utilization of Infusion Pumps?

Asia Pacific is anticipated to witness the fastest growth in the infusion pump market driven by the disparities in healthcare development across the region creating a varied landscape for infusion pump adoption. In economically advanced areas, such as the Gulf Cooperation Council (GCC) countries, state-of-the-art medical facilities are equipped with modern infusion technologies, driving high utilization rates. These nations often have well-funded healthcare systems that can afford and maintain advanced infusion pumps. However, in less developed parts of Africa and conflict-affected areas of the Middle East, healthcare infrastructure is often underdeveloped or damaged. This leads to limited availability of infusion pumps, with many facilities relying on older, less sophisticated models or manual infusion methods. The stark contrast in resources affects not only the distribution of infusion pumps but also the types of pumps available in different areas.

Challenges in maintenance, training, and supply chain logistics significantly influence the utilization of infusion pumps. Many parts of the Middle East & Africa face difficulties in ensuring consistent power supply and maintaining sterile conditions, which are crucial for the proper functioning of infusion pumps. Additionally, there's often a shortage of trained healthcare professionals who can operate and maintain these devices effectively. Supply chain issues, including difficulties in importing replacement parts and consumables, can lead to prolonged periods of pump inactivity. These factors result in underutilization of available infusion pumps and reluctance among some healthcare providers to invest in more advanced models, despite their potential benefits. Consequently, efforts to improve infusion pump utilization in the region often focus not just on increasing availability, but also on enhancing infrastructure, training, and supply chain resilience.

Competitive Landscape

The Infusion Pump Market is highly competitive, characterized by rapid technological advancements, increasing demand for precision in drug delivery, and a focus on enhancing patient safety and regulatory compliance across healthcare settings.

Some of the prominent players operating in the infusion pump market include:

Becton

Dickinson, and Company

Braun Melsungen

Baxter International

Fresenius Kabi

ICU Medical

Medtronic

Moog Inc.

Smiths Medical

Terumo Corporation

Roche Diagnostics

Infusion Pump Market Latest Developments

In March 2024, Medtronic announced the launch of an AI-powered smart infusion system Medtronic introduced a new infusion pump with integrated artificial intelligence capabilities. The system uses machine learning algorithms to predict potential infusion errors and optimize drug delivery rates, significantly enhancing patient safety and treatment efficacy.

In January 2024, B. Braun expanded its infusion pump portfolio with the acquisition of B. Braun Melsungen AG a startup specializing in miniature infusion pump technology. This strategic move allows B. Braun to enter the wearable infusion pump market, targeting ambulatory care and home healthcare segments.

In November 2023, Baxter International announced the launch of a cybersecurity-enhanced pump Baxter a new line of infusion pumps with advanced cybersecurity features.

Infusion Pump Market, By Category

• Application:
• Chemotherapy/Oncology
• Diabetes
• Gastroenterology
• End-User:
• Hospitals
• Home Care Settings
• Ambulatory Care Settings
• Academic & Research Institutes
• Geography:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL INFUSION PUMP MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 2.1 Data mining
• 2.2 Secondary research
• 2.3 Primary research
• 2.4 Subject matter expert advice
• 2.5 Quality check
• 2.6 Final review
• 2.7 Data Triangulation
• 2.8 Bottom-up approach
• 2.9 Top-down approach
• 2.10 Research flow
• 2.11 Data sources

3 EXECUTIVE SUMMARY

• 3.1 Overview
• 3.2 Absolute $ Opportunity
• 3.3 Market attractiveness
• 3.4 Future Market Opportunities

4 GLOBAL INFUSION PUMP MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL INFUSION PUMP MARKET, BY APPLICATION

• 5.1 Overview
• 5.2 Chemotherapy/Oncology
• 5.3 Diabetes
• 5.4 Gastroenterology
• 5.5 Analgesia/Pain Management
• 5.6 Pediatrics/Neonatology
• 5.7 Hematology
• 5.8 Other

6 GLOBAL INFUSION PUMP MARKET, BY END-USER

• 6.1 Overview
• 6.2 Hospitals
• 6.3 Home Care Settings
• 6.4 Ambulatory Care Settings
• 6.5 Academic & Research Institutes

7 GLOBAL INFUSION PUMP MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Argentina
  • 7.5.3 Rest of LA
• 7.6 Middle East & Africa
  • 7.6.1 UAE
  • 7.6.2 Saudi Arabia
  • 7.6.3 South Africa
  • 7.6.4 Rest of MEA

8 GLOBAL INFUSION PUMP MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies
• 8.4 Company Regional Footprint
• 8.5 Company Industry Footprint
• 8.6 ACE Matrix

9 COMPANY PROFILES

• 9.1 Becton, Dickinson and Company
  • 9.1.1 Company Overview
  • 9.1.2 Company Insights
  • 9.1.3 Business Breakdown
  • 9.1.4 Product Benchmarking
  • 9.1.5 Key Developments
  • 9.1.6 Winning Imperatives
  • 9.1.7 Current Focus & Strategies
  • 9.1.8 Threat from Competition
  • 9.1.9 SWOT Analysis
• 9.2 Roche Diagnostics
  • 9.2.1 Company Overview
  • 9.2.2 Company Insights
  • 9.2.3 Business Breakdown
  • 9.2.4 Product Benchmarking
  • 9.2.5 Key Developments
  • 9.2.6 Winning Imperatives
  • 9.2.7 Current Focus & Strategies
  • 9.2.8 Threat from Competition
  • 9.2.9 SWOT Analysis
• 9.3 B. Braun Melsungen
  • 9.3.1 Company Overview
  • 9.3.2 Company Insights
  • 9.3.3 Business Breakdown
  • 9.3.4 Product Benchmarking
  • 9.3.5 Key Developments
  • 9.3.6 Winning Imperatives
  • 9.3.7 Current Focus & Strategies
  • 9.3.8 Threat from Competition
  • 9.3.9 SWOT Analysis
• 9.4 Baxter International
  • 9.4.1 Company Overview
  • 9.4.2 Company Insights
  • 9.4.3 Business Breakdown
  • 9.4.4 Product Benchmarking
  • 9.4.5 Key Developments
  • 9.4.6 Winning Imperatives
  • 9.4.7 Current Focus & Strategies
  • 9.4.8 Threat from Competition
  • 9.4.9 SWOT Analysis
• 9.5 Fresenius Kabi
  • 9.5.1 Company Overview
  • 9.5.2 Company Insights
  • 9.5.3 Business Breakdown
  • 9.5.4 Product Benchmarking
  • 9.5.5 Key Developments
  • 9.5.6 Winning Imperatives
  • 9.5.7 Current Focus & Strategies
  • 9.5.8 Threat from Competition
  • 9.5.9 SWOT Analysis
• 9.6 ICU Medical
  • 9.6.1 Company Overview
  • 9.6.2 Company Insights
  • 9.6.3 Business Breakdown
  • 9.6.4 Product Benchmarking
  • 9.6.5 Key Developments
  • 9.6.6 Winning Imperatives
  • 9.6.7 Current Focus & Strategies
  • 9.6.8 Threat from Competition
  • 9.6.9 SWOT Analysis
• 9.7 Medtronic
  • 9.7.1 Company Overview
  • 9.7.2 Company Insights
  • 9.7.3 Business Breakdown
  • 9.7.4 Product Benchmarking
  • 9.7.5 Key Developments
  • 9.7.6 Winning Imperatives
  • 9.7.7 Current Focus & Strategies
  • 9.7.8 Threat from Competition
  • 9.7.9 SWOT Analysis
• 9.8 Moog Inc.
  • 9.8.1 Company Overview
  • 9.8.2 Company Insights
  • 9.8.3 Business Breakdown
  • 9.8.4 Product Benchmarking
  • 9.8.5 Key Developments
  • 9.8.6 Winning Imperatives
  • 9.8.7 Current Focus & Strategies
  • 9.8.8 Threat from Competition
  • 9.8.9 SWOT Analysis
• 9.9 Smiths Medical
  • 9.9.1 Company Overview
  • 9.9.2 Company Insights
  • 9.9.3 Business Breakdown
  • 9.9.4 Product Benchmarking
  • 9.9.5 Key Developments
  • 9.9.6 Winning Imperatives
  • 9.9.7 Current Focus & Strategies
  • 9.9.8 Threat from Competition
  • 9.9.9 SWOT Analysis
• 9.10 Terumo Corporation
  • 9.10.1 Company Overview
  • 9.10.2 Company Insights
  • 9.10.3 Business Breakdown
  • 9.10.4 Product Benchmarking
  • 9.10.5 Key Developments
  • 9.10.6 Winning Imperatives
  • 9.10.7 Current Focus & Strategies
  • 9.10.8 Threat from Competition
  • 9.10.9 SWOT Analysis
• 9.11 Roche Diagnostics
  • 9.11.1 Company Overview
  • 9.11.2 Company Insights
  • 9.11.3 Business Breakdown
  • 9.11.4 Product Benchmarking
  • 9.11.5 Key Developments
  • 9.11.6 Winning Imperatives
  • 9.11.7 Current Focus & Strategies
  • 9.11.8 Threat from Competition
  • 9.11.9 SWOT Analysis

10 Appendix

• 10.1 Related Research
• 10.2 Key Developments